---
title: Cellab CDMO vs Cell Therapies
slug_a: cellab
slug_b: celltherapies
site: cdmo
review_signal_gate: closed
canonical_path: /compare/cellab/celltherapies
generated_by: BioBM Editorial AI
---

# Cellab CDMO vs Cell Therapies

This comparison is auto-generated by BioBM Editorial AI and intended as an evidence-oriented side-by-side reference.

## Company A

Cellab CDMO (cellab) is listed for cdmo. Cell and gene therapy CDMO providing cell banking, GMP manufacturing, cryopreservation and EU QP batch release for clinical-stage ATMPs. Operates a 1,000 m² facility with four Grade B and one Grade C cleanroom plus an AABB-accredited cell bank.

Services: 7. Modalities: 2. Indications: 0. Locations: 1. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (7).

Review summary: Review summary withheld until site-level review gate opens.

## Company B

Cell Therapies (celltherapies) is listed for cdmo. GMP contract manufacturer of autologous and allogeneic cell therapies from first-in-human trials through commercial supply, with two decades of experience in CAR-T, mesenchymal stromal cells, TILs, and pluripotent stem cell derivatives. Offers end-to-end cold chain management, process development, quality control analytics, and regulatory consulting across Australia and Asia-Pacific.

Services: 9. Modalities: 2. Indications: 1. Locations: 1. Certifications: 4. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (9).

Review summary: Review summary withheld until site-level review gate opens.